Fast Acting Arthritogenic Monoclonal Antibody Cocktails

Collagen Antibody-Induced Arthritis (CAIA) has been widely used since 1998 when 4-clone cocktail (Arthrogen-CIA® arthritogenic monoclonal antibodies) kits first appeared. In order to induce consistent arthritis more effectively in various mouse strains including CAIA low responder C57BL/6 mice, and a variety of unpredictable knockout and transgenic mice with C57BL/6 (H-2b) or 129/Sv (H-2b) backgrounds, a [...]

ChemAxon provides chemistry informatics platform for the European Lead Factory

ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and the European Lead Factory, a novel platform for innovative drug discovery, announces that ChemAxon will provide the core tools and leads the development of the informatics platform to support the pan European initiative. ChemAxon will be building a portal [...]

Roche and Hamilton Introduce New Automated DNA Sample Enrichment Platform for GS Junior Sequencing Instruments

Today Roche and Hamilton Robotics jointly announced the introduction of a new, integrated platform enabling automated DNA sample enrichment for Roche’s 454 GS Junior sequencer. The platform builds on the integration of Roche’s REM e System with Hamilton’s Microlab® NIMBUS NGS workstation, resulting in reduced hands-on time, minimized operational variability and more consistent results. “This [...]

SPECTRO Presents XRF Package of Methods for Cement Industry

Kleve, — SPECTRO plans to present an elemental screening package for the cement industry at the seventh Global CemFuels Conference, March 11 to 14, 2013 in Istanbul. X-ray fluorescence analysis (XRF) has become especially useful for determining harmful substances in secondary fuels and has become a favorite technology, because of its ability to rapidly conduct [...]

Tecan Group AG : Tecan appoints Dr. Stefan Traeger to the Management Board

Männedorf, Switzerland, - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has appointed Dr. Stefan Traeger as a member of the Management Board. As Head of the Life Sciences Business division Stefan Traeger will be responsible for the Group's global end-customer business. He will take up his new post at Tecan on [...]

BioGenes Reports Strong Growth of HCP Assay Development Business

Berlin, Germany, - BioGenes GmbH, a global leader in host cell protein (HCP) assay development, announced a strong increase in sales volume in 2012, the year of the company’s 20th anniversary, due to a high demand of specific antibodies and ELISA assays used in drug development processes. In particular, the HCP assay development business showed [...]

Spring rebate on EdU cell proliferation kits

30% spring rebate on EdU cell proliferation kits Offer ends March 31, 2013! PANATecs GmbH is once again expanding its life-science tools portfolio, placing an emphasis on mass-spectroscopy services for biopharmaceutical applications. After entering into a distribution partnership with BASF subsidiary Baseclick in December 2012, PANATecs GmbH now offers patented click chemistry products. Available beginning [...]

Certara Releases Version 7.0 of D360

ST. LOUIS -- Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through clinical development, is pleased to announce the next major release of D360, version 7.0. “Through close collaboration with our clients we have been able to develop a set of features that further advance [...]

Agilent Technologies Thought Leader Award Supports Dr. Ronald A. DePinho and Translational Research Program at MD Anderson Cancer Center

Agilent Technologies Inc. (NYSE: A) today announced that Dr. Ronald A. DePinho, a world-renowned oncologist and researcher, has received an Agilent Thought Leader Award. DePinho is president of the University of Texas MD Anderson Cancer Center. The award will support his research into metabolic reprogramming in the earliest stages of cancer. DePinho and his team [...]

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass.--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on April 15, 2013, to shareholders of record as of March 15, 2013. About Thermo Fisher Scientific Thermo Fisher Scientific [...]

Access IBO on Knowledge Center